Eisaku Iwanaga
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 10
- Acute Myeloid Leukemia Research 7
-
- Chronic Lymphocytic Leukemia Research 5
-
- Acute Lymphoblastic Leukemia research 3
-
- Cutaneous lymphoproliferative disorders research 2
-
- Eosinophilic Disorders and Syndromes 4
-
- Antibiotic Use and Resistance 2
-
- Fungal Infections and Studies 2
Eisaku Iwanaga
18 papers receiving 176 citations
Peers
Comparison fields: 5 of 36
- Hematology 122
- Genetics 47
- Cancer Research 31
- Public Health, Environmental and Occupational Health 42
- Dermatology 11
Countries citing papers authored by Eisaku Iwanaga
This map shows the geographic impact of Eisaku Iwanaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eisaku Iwanaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eisaku Iwanaga more than expected).
Fields of papers citing papers by Eisaku Iwanaga
This network shows the impact of papers produced by Eisaku Iwanaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eisaku Iwanaga. The network helps show where Eisaku Iwanaga may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eisaku Iwanaga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2020 | 4 | |
| 9 | 2019 | 38 | |
| 10 | 2018 | 6 | |
| 11 | 2018 | 1 | |
| 12 | 2014 | 38 | |
| 13 | 2013 | 24 | |
| 14 | 2013 | 10 | |
| 15 | 2009 | 7 | |
| 16 | 2009 | 19 | |
| 17 | 2007 | 7 | |
| 18 | 2006 | 9 | |
| 19 | 2005 | 7 |
About Eisaku Iwanaga
Eisaku Iwanaga is a scholar working on Hematology, Applied Microbiology and Biotechnology and Genetics, having authored 19 papers that have together received 179 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (10 papers), Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Antibiotic Use and Resistance (2 papers), Fungal Infections and Studies (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). The work is most often cited by research in Hematology (122 citations), Genetics (47 citations) and Cancer Research (31 citations). Eisaku Iwanaga has collaborated with scholars based in Japan and Singapore. Frequent co-authors include Norio Asou, Hiroaki Mitsuya, Tomoko Nanri, Kenji Tokunaga, Hitoshi Suzushima, Taizo Shimomura, Toshiro Kawakita, Naokuni Uike, Takashi Sonoki and Sho Kubota. Their work appears in journals such as International Journal of Hematology, Blood, European Journal Of Haematology, Infection Control and Hospital Epidemiology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.